Abstract:A rational approach was adopted to design high-potential metal-based antitumor agents. A series of organometallic Pd(ii) complexes with a general formula of [Pd{κ2(C,C)-[(C6H4-2)PPh2]CH(CO)C6H4Ph-4}{κ2(N,O)}] (N,O = alanine (Pd-A), valine (Pd-V), leucine (Pd-L), l-isoleucine (Pd-I) and phenylalanine (Pd-F)) were prepared by cyclopalladation of the phosphorus ylide, bridge cleavage reaction and subsequent chelation of natural α-amino acids. The complexes were fully identified using IR and multinuclear 1H, 13C, 31P NMR spectroscopic methods. X-ray crystallography exhibited that the Pd(ii) atom is located in a slightly distorted square-planar environment surrounded by C,C-orthometallated phosphorus ylide as well as NO-pendant amino acid functionality. In vitro cytotoxicity evaluation of new cyclometallated Pd(ii) complexes toward a human leukemia (K562) cancer cell line indicated promising results. The highest cytotoxic activity was discovered in the case of phenylalanine (CH2C6H5). IC50 values of this complex on a panel of human tumor cell lines representative of liver (HepG2), breast (SKBR-3), and ovarian (A2780-Resistance/Sensitive) cancers also indicated promising antitumor effects in comparison with standard cisplatin. The binding interaction ability of the phenylalanine-containing orthopalladated complex, as the most efficient compound, with calf-thymus deoxyribonucleic acid (CT-DNA) and bovine serum albumin (BSA) was investigated. UV-Vis spectroscopy, competitive emission titration, and circular dichroism (CD) techniques demonstrated the intercalative binding of the Pd(ii) complex with DNA. Molecular docking studies also fully agreed with the experimental data. Examination of the reactivity towards the protein BSA revealed that the static quenching mechanism of BSA intrinsic fluorescence by the Pd(ii) complex with a binding constant (Kb) of ∼105 is indicative of the high affinity of the complex. The competitive binding experiment using site markers with definite binding sites demonstrated that the hydrophobic cavities of site I (subdomain IIA) are responsible for the bimolecular interaction between protein BSA and the complex. Molecular docking studies effectively confirmed the significance of hydrophobic interactions in Pd(ii)-BSA binding. The results of this study could greatly contribute to exploring new potent metal-based anticancer drugs.

Synthesis, Characterization and Interaction with Bovine Serum Albumin of Cyclometallated Pd(Ii) Complexes Containing Arylimine and Salicylaldimine Co-Ligands

Synthesis, characterization of Ag(I), Pd(II) and Pt(II) complexes of a triazine-3-thione and their interactions with bovine serum albumin.

Synthesis and Characterization Some Transition Metal Complexes of New Ligand Chalcone-Azo Derivatives from P-methoxy-4, 5-diphenyl Imidazole and Study Biological Effect of Pd(II) Complex

Synthesis, Crystal Structure of Copper Complexes of DL-Valinato Schiff Base with N,N '-Heterocyclic Bases and the Interaction with BSA

A 3D copper (II) coordination polymer based on sulfanilic acid ligand (CP 1) for efficient biomolecular interaction with bovine serum albumin: spectroscopic, molecular modelling and DFT analysis.

Analysis of Binding Interaction Between Bovine Serum Albumin and the Cobalt(Ii) Complex with Salicylaldehyde-2-Phenylquinoline-4-Carboylhydrazone

Synthesis of bimetallic palladacycles via C H bond activation: Crystal structure, DNA binding and in vitro cytotoxicity study

Synthesis and Liquid Crystal Properties of Dinuclear Cyclopalladated 5-Alkyl-2-(4′-alkoxyphenyl)pyrimidine and 3-(4′-alkoxyphenyl)-6-alkoxypyridazine Complexes

Cationic Pyridinium Porphyrins Appending Different Peripheral Substituents: Spectroscopic Studies on Their Interactions with Bovine Serum Albumin.

Synthesis and BSA binding study of the Cu(II) complex and applications of it to enhance catalytic activity for C(Sp 2 )-H bond functionalization and for the synthesis of polyhydroquinolines

Analysis of the binding mechanism for a water-soluble Pd(II) complex containing β-amino alcohols with HSA applying experimental and computational methods

Synthesis, Characterization, and Catalytic Activity of (1,2-Diaryl)alkenylphosphine Palladium Complexes

Potent cyclometallated Pd(II) antitumor complexes bearing α-amino acids: synthesis, structural characterization, DNA/BSA binding, cytotoxicity and molecular dynamics simulation

Synthesis, crystal structure, spectral characterization, catalytic studies and computational studies of Ni(II) and Pd(II) complexes of symmetrical tetradentate Schiff base ligand

Synthesis, Luminescence Properties of Eu (III) and Tb (III) Complexes with a Polyamine Polycarboxylic Ligand as well as Their Binding Characteristics with Bovine Serum Albumin (BSA)

Comparative Linkage of Novel Anti-Tumor Pd(II) Complex with Bio-Macromulecules: Fluorescence, UV-Vis, DFT, Molecular Docking and Molecular Dynamics Simulation Studies

A mechanism – based perspective on the interplay of new drug candidate with biomolecules

Comparative Investigation of Interactions Between Two Ruthenium(ii) Arene PTA Type Complexes with Curcuminoid Ligands and Human Serum Albumin

Comparative investigation on interaction mechanism and native conformation of human serum albumin with organometallic iridium(III) complexes via spectroscopic and electrochemical approaches

Synthesis, Characterization of Conjugated Oligo-Phenylene-ethynylenes and Their Supramolecular Interaction with Β-Cyclodextrin for Salicylaldehyde Detection

Computational and experimental examinations of new antitumor palladium(II) complex: CT-DNA-/BSA-binding, in-silico prediction, DFT perspective, docking, molecular dynamics simulation and ONIOM